Currently, the most studied checkpoint proteins in vitro and with the highest clinical relevance are cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), programmed cell death protein-1 (PDCD1), and programmed cell death ligand 1 (PD-L1) for HCC patients [47]. Here, PDCD1 is linked to hepatocellular carcinoma.